Who owns IONIS PHARMACEUTICALS INC?
- CUSIP Number: 462222ad2
Tip: Access positions for across all investors
Analyze quarterly positions in Ionis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ionis Pharmaceuticals stock
Who bought or sold IONIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Steelhead Partners | 54M | $53B | -3% | Mar 2024 |
|
| Tenor Capital Management | 52M | $51B | 62% | Mar 2024 |
|
| Citadel Advisors | 52M | $51M | 2% | Mar 2024 |
|
| Lazard Asset Management | 46M | $48M | 0% | Dec 2023 |
|
| CSS | 32M | $32M | 0% | Mar 2024 |
|
| Capstone Investment Advisors | 31M | $31M | 11% | Mar 2024 |
|
| MacKay Shields | 30M | $29M | -1% | Mar 2024 |
|
| Wells Fargo & Company | 20M | $20M | 0% | Mar 2024 |
|
| Nuveen Asset Management | 20M | $20M | 28% | Mar 2024 |
|
| Calamos Advisors | 17M | $17M | -1% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 15M | $15M | 0% | Mar 2024 |
|
| Aviva | 15M | $15M | 0% | Mar 2024 |
|
| Shenkman Capital Management | 15M | $15B | 34% | Mar 2024 |
|
| Lombard Odier Asset Management | 15M | $15M | 100% | Mar 2024 |
|
| DeepCurrents Investment Group | 14M | $14M | -32% | Mar 2024 |
|
| BlackRock | 13M | $13M | -60% | Mar 2024 |
|
| Sonora Investment Management Group | 13M | $12M | -1% | Mar 2024 |
|
| Mint Tower Capital Management B.V. | 10M | $9.9M | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 9.6M | $9.4M | -6% | Mar 2024 |
|
| Axa | 8.5M | $8.4M | 167% | Mar 2024 |
|
| Walleye Trading Advisors | 7.5M | $7.4M | 25% | Mar 2024 |
|
| Morgan Stanley | 6.8M | $6.7M | -15% | Mar 2024 |
|
| SSI Investment Management | 6.5M | $6.8M | 1307% | Dec 2023 |
|
| Leucadia National Corporation | 6.1M | $6.0M | 225% | Mar 2024 |
|
| Verition Fund Management | 4.3M | $4.3M | 67400% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 4.3M | $4.2M | 0% | Mar 2024 |
|
| Royal Bank of Canada | 3.5M | $3.5M | -1% | Mar 2024 |
|
| Man Group | 2.9M | $2.9M | -18% | Mar 2024 |
|
| Susquehanna International | 2.5M | $2.5M | 100% | Mar 2024 |
|
| Citigroup | 2.3M | $2.3M | 100% | Mar 2024 |
|
| Barclays | 1.5M | $1.5M | -24% | Mar 2024 |
|
| Jane Street | 1.1M | $1.1M | 100% | Mar 2024 |
|
| Kohlberg Kravis Roberts & Co | 840k | $831k | 20% | Mar 2024 |
|
| Bank of New York Mellon | 800k | $792k | 0% | Mar 2024 |
|
| Credit Suisse | 761k | $730k | 65% | Mar 2024 |
|
| Jpmorgan Chase & Co | 535k | $530k | 100% | Mar 2024 |
|
| Russell Investments | 521k | $514k | -20% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 500k | $495k | 100% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 500k | $495k | 0% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 338k | $334k | 100% | Mar 2024 |
|
| Sei Investments | 259k | $255k | 0% | Mar 2024 |
|
| KBC Group NV | 200k | $198k | 0% | Mar 2024 |
|
| Calamos Wealth Management | 137k | $135k | 2% | Mar 2024 |
|
| First Hawaiian Bank | 127k | $125k | 0% | Mar 2024 |
|
| Oppenheimer Asset Management | 56k | $55k | -45% | Mar 2024 |
|
| Stephens | 49k | $48k | 123% | Mar 2024 |
|
| Argent Trust | 25k | $25k | 0% | Mar 2024 |
|
| Balboa Wealth Partners | 17k | $17k | 0% | Mar 2024 |
|
| Brian McDonald | 1.0k | $984.000000 | 0% | Mar 2024 |
|
Who sold out of Ionis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wolverine Asset Management | Dec 2023 | 22M | $24M |
| Braidwell | Dec 2023 | 5.2M | $5.5M |
| Linden Advisors | Sep 2023 | 1.8M | $1.7B |
| Boussard & Gavaudan Investment Management | Sep 2023 | 5.3k | $5.2M |
| UBS Group | Dec 2023 | 1.0k | $1.1k |